Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
23.04
+1.11 (5.06%)
At close: Jan 21, 2025, 4:00 PM
23.00
-0.04 (-0.17%)
After-hours: Jan 21, 2025, 5:08 PM EST
Denali Therapeutics Analyst Ratings
Total Analysts
13
Consensus Rating
Strong Buy
Price Target
$38.91
Upside
+68.88%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $28 → $24 | Buy | Maintains | $28 → $24 | +4.17% | Jan 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $90 → $87 | Strong Buy | Maintains | $90 → $87 | +277.60% | Jan 7, 2025 |
| Baird | Baird | Buy Initiates $31 | Buy | Initiates | $31 | +34.55% | Jan 7, 2025 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jan 3, 2025 |
| Stifel | Stifel | Hold → Strong Buy Upgrades $37 | Hold → Strong Buy | Upgrades | $37 | +60.59% | Dec 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $90 | Strong Buy | Reiterates | $90 | +290.63% | Nov 7, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $40 → $45 | Strong Buy | Maintains | $40 → $45 | +95.31% | Nov 1, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $29 → $28 | Buy | Maintains | $29 → $28 | +21.53% | Oct 11, 2024 |
| Raymond James | Raymond James | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 10, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $35 | Buy | Reiterates | $35 | +51.91% | Sep 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $90 | Strong Buy | Reiterates | $90 | +290.63% | Sep 4, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $25 → $29 | Strong Buy | Maintains | $25 → $29 | +25.87% | Sep 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $90 | Strong Buy | Reiterates | $90 | +290.63% | Aug 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $95 → $90 | Strong Buy | Maintains | $95 → $90 | +290.63% | Aug 5, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $26 → $32 | Strong Buy | Maintains | $26 → $32 | +38.89% | Aug 2, 2024 |
| Wedbush | Wedbush | Buy Maintains $30 → $26 | Buy | Maintains | $30 → $26 | +12.85% | Aug 2, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.